Zoledronic acid
Also known as: Zoledronate
Active ingredient description
Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Medicines
Zoledronic acid is the active ingredient of these drugs:
Turkey
Australia Austria Brazil Canada Cyprus
Singapore
Germany
Turkey
Germany
Brazil
South Africa
Turkey
Turkey
Turkey
Turkey
Brazil Ecuador
Poland
Australia
South Africa
Poland
Turkey
Turkey
Ecuador
Turkey
Tunisia
Turkey
Cyprus
Poland
Turkey
Ecuador
Australia
Turkey
Turkey
Japan United States
South Africa
Germany Lithuania
Turkey
Turkey
Ecuador
Ecuador
Ecuador
Brazil
Turkey
Turkey
Estonia Lithuania
Ireland Poland Romania
Ecuador
Ecuador
Ecuador
Brazil Ecuador Singapore South Africa
Ecuador South Africa
Turkey
Ecuador
Estonia Lithuania
South Africa
Turkey
Singapore
Hong Kong Turkey
Australia
Tunisia
Turkey
Turkey
Turkey
Singapore
Turkey
Brazil
Singapore
Turkey
Turkey
Turkey
Turkey
Singapore
Turkey
South Africa
Turkey
South Africa
South Africa
Australia Austria Brazil Canada Cyprus
Poland
Turkey
Turkey
South Africa
Singapore
Zoledronic acid is also found within below combination drugs:
Structural formula
Chemical formula: C₅H₁₀N₂O₇P₂
Molecular mass: 272.09 g/mol